Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$104K Buy
259
+237
+1,077% +$151K ﹤0.01% 2405
2017
Q1
$17K Sell
22
-33
-60% -$28.4K ﹤0.01% 2990
2016
Q4
$46K Buy
+55
New +$126K ﹤0.01% 3106
2015
Q4
Sell
-15
Closed -$69K 3698
2015
Q3
$69K Buy
+15
New +$89.5K ﹤0.01% 2928
2014
Q4
Sell
-4
Closed -$31K 3970
2014
Q3
$31K Sell
4
-2
-33% -$17.4K ﹤0.01% 3420
2014
Q2
$55K Buy
+6
New +$53.6K ﹤0.01% 3418
2013
Q4
Sell
-2
Closed -$24K 3997
2013
Q3
$24K Buy
+2
New +$29.6K ﹤0.01% 3601

Other funds holding IMNN

Virtu KCG Holdings's IMNN Position: Q2 2017 in Review

Virtu KCG Holdings increased its Imunon (IMNN) stake by 1,077% in Q2 2017, buying an estimated $151K and bringing the position to 259 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #2405.

Virtu KCG Holdings first reported a position in IMNN in Q3 2013 and has held it in 7 quarters since. 15 funds tracked by Wall St. Rank hold IMNN as of Q2 2017.

  • Virtu KCG Holdings held 259 shares of Imunon worth $104K as of Q2 2017.
  • Virtu KCG Holdings bought 237 Imunon shares in Q2 2017, an estimated $151K.
  • Imunon made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2405 holding.
  • Virtu KCG Holdings first reported a position in Imunon in Q3 2013 and has held it in 7 quarters since.
  • 15 funds tracked by Wall St. Rank held Imunon as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.